Dr. Ataga is the director of the UNC Comprehensive Sickle Cell Program. His clinical research is focused on the vasculopathy of sickle cell disease, with an emphasis on pulmonary hypertension and renal complications, and coagulation activation in sickle cell disease. In addition, he has a strong research interest in the...

Nigel Mackman, PhD, John Parker Distinguished Professor of Medicine in the Division of Hematology/Oncology, has been selected by the American Heart Association and the Council on Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) to receive the 2017 ATVB Distinguished Achievement Award.

William A. Fischer II, M.D., an assistant professor in the division of pulmonary and critical care medicine and David A. Wohl, M.D., in the division of infectious diseases discuss how the Ebola virus RNA can persist in the semen of survivors more than two years after the onset of infection.

“In many areas of rural areas of sub-Saharan Africa, malaria is inevitable. Children will be infected,” said Ross Boyce, M.D., MS.c., study author and a fellow in the UNC Division of Infectious Diseases.

A team of UNC researchers will use funds from the Gillings School of Global Public Health to test two interventions to prevent mother-to-child transmission of hepatitis B virus in the Democratic Republic of the Congo (DRC).

The ability for HIV to hide in the body in a dormant state makes curing the 40 million people living with the virus a challenge. Researchers at the University of North Carolina at Chapel Hill have shown the drug Vorinostat reverses this latency, causing resting CD4 T-cells to express HIV.

"Because of how society views the medical profession, physicians are leaders. Whether you knew this or not when you started your first day, you are. Leaders communicate a vision, engender trust and buy-in of those they are leading, and nurture a spirit of teamwork to enable realization of that vision."...

Speaker: Christopher Kontos, MD. Associate Professor of Medicine, Duke UniversityTopic: “New Insights into Skeletal Muscle-Endothelial Cell Interactions in Peripheral Artery Disease” Presentation Preview: Peripheral artery disease (PAD) is caused by atherosclerotic obstruction of the peripheral arteries, most commonly the legs. The clinical manifestations of PAD include intermittent claudication, characterized by...

Speaker: Kristy Red-Horse, PhD, Assistant Professor, Department of Biology, Stanford UniversityTopic: Coronary Artery Development: Transcriptional Regulation of Blood Flow Guided Behaviors

This educational activity will provide a refresher on optimal treatment of various cardiovascular diseases. New technologies and drug therapies will be discussed, and challenging cases will be reviewed to put current treatment recommendations in perspective. The Mountain Area Health Education Center designates this live educational activity for a maximum of...

Dr. Fuster is Physician-in-Chief of Mount Sinai Hospital.

Dr. Fuster is Physician-in-Chief of Mount Sinai Hospital.